Summit Speakers

David Younger, PhD, is the Co-Founder and CEO of A-Alpha Bio, a Seattle-based biotechnology company that generates experimental data at the scale modern AI protein engineering models require. David invented A-Alpha's AlphaSeq platform, which measures millions of protein-protein binding affinities in a single experiment, with David Baker and Eric Klavins at the University of Washington, where he earned his PhD in Bioengineering. In July 2026, A-Alpha launched the Atlas Data Consortium, a cooperative business model in which members design experiments each quarter and receive non-exclusive licenses to every dataset the consortium produces.